Comparison Between First-Line Target Therapy And Immunotherapy In Different Prognostic Categories Of Braf Mutant Metastatic Melanoma PatientsR. Marconcini,P. Fava,F. De Rosa,M. De Tursi, E. T. Tanda,F. Consoli, G. Targato, N. Pimpinelli,F. Morgese,M. Bersanelli,M. G. Tucci, M. Saponara,A. Cortellini, M. Ocelli,R. Morganti, S. Manacorda, S. Bazzurri,A. Nuzzo,M. Ferrari,A. FalconeANNALS OF ONCOLOGY(2021)引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要